See every side of every news story
Published loading...Updated

J&J resumes PFA cases, but analysts warn safety may hamper rollout

Summary by medtechdive.com
J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”

1 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

medtechdive.com broke the news in on Tuesday, February 18, 2025.
Sources are mostly out of (0)